[Thymoma and squamous thymic carcinoma diagnosis; experience from the RYTHMIC network].

Diagnostic des thymomes et carcinomes thymiques malpighiens ; expérience du réseau RYTHMIC.
Carcinome thymique Immunohistochemistry Immunohistochimie RYTHMIC Stade Stage Thymic carcinoma Thymoma Thymome

Journal

Annales de pathologie
ISSN: 0242-6498
Titre abrégé: Ann Pathol
Pays: France
ID NLM: 8106337

Informations de publication

Date de publication:
Apr 2021
Historique:
received: 18 07 2020
revised: 10 10 2020
accepted: 11 11 2020
pubmed: 15 12 2020
medline: 16 10 2021
entrez: 14 12 2020
Statut: ppublish

Résumé

The RYTHMIC network, supported by the French National Cancer Institute is dedicated to the management of patients with thymic epithelial tumors through regional and national multidisciplinary tumor boards. Tumor board decisions are based on the initial pathology diagnoses. However, following clinical inclusion in the network, a central pathology review is organized, implicating a panel of pathologists, for histotype and stage classification, which is different from a classical second opinion from pathologist to pathologist for a difficult case. Thanks to the participation of all French pathologists, more than 1000 cases have been reviewed by the panel. The aim of this review is to share with the French pathology community, the experience of the group. It underlines the importance of macroscopy and surgeon-pathologist involvement to allow a good central review, the main histopathological and immunophenotypical patterns of the most frequent thymomas and thymic carcinoma types, the differential diagnoses, as well as the difficulties for the panel to reproducibly assess on slides, stage, for some cases.

Identifiants

pubmed: 33309329
pii: S0242-6498(20)30268-6
doi: 10.1016/j.annpat.2020.11.002
pii:
doi:

Types de publication

Journal Article Review

Langues

fre

Sous-ensembles de citation

IM

Pagination

154-165

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

Lara Chalabreysse (L)

Département de pathologie, groupement hospitalier est, hospices civils de Lyon, Lyon, France.

Romain Dubois (R)

Institut de pathologie, CHU de Lille, Lille, France.

Véronique Hofman (V)

Laboratoire de pathologie clinique et expérimentale, FHU OncoAge, Biobank 0033-00025, université Côte d'Azur, hôpital Pasteur, Nice, France.

Cécile Le Naoures (C)

Département de pathologie, CHU de Rennes, Rennes, France.

Audrey Mansuet-Lupo (A)

Inserm U1138, centre de recherche des Cordeliers, département de pathologie, université de Paris, hôpital universitaire Cochin, AP-HP centre, Paris, France.

Vincent Thomas de Montpréville (VT)

Département de pathologie, hôpital Marie-Lannelongue, Le plessis-Robinson, France.

Anne De Muret (A)

Service d'anatomie pathologique, CHU de Tours, Tours, France.

Marie Parrens (M)

Inserm U1053, service d'anatomie pathologique, CHU de Bordeaux, université de Bordeaux, Bordeaux, France.

Nicolas Piton (N)

Inserm U1245, service de pathologie, CHU de Rouen, Rouen, France.

Isabelle Rouquette (I)

Laboratoire d'anatomie pathologique, CHU de Toulouse oncopole, Toulouse, France.

Véronique Secq (V)

Département de pathologie, AP-HM Marseille, Marseille, France.

Cristina Singeorzan (C)

Service d'anatomie pathologique, CHU de Besançon, Besançon, France.

Alexander Marx (A)

Institut de pathologie, université médicale de Mannheim, université de Heidelberg, Mannheim, Allemagne.

Nicolas Girard (N)

Institut du thorax Curie Montsouris, institut Curie, Paris, France.

Benjamin Besse (B)

Département de médecine oncologique, institut Gustave-Roussy, Villejuif, France; Paris-Sud-université, Orsay, France.

Thierry Jo Molina (TJ)

Inserm U1163, service d'anatomie pathologique, institut imagine, université de Paris, hôpital universitaire Necker-Enfants malades, AP-HP centre, 149, rue de Sèvres, 75015 Paris, France. Electronic address: thierry.molina@%20aphp.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH